PRIMA PFO Migraine Trial

PHASE2TerminatedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
MigraineMigraine With AuraPatent Foramen OvalePFO
Interventions
DEVICE

AMPLATZER® PFO Occluder Device

PFO device closure

Trial Locations (17)

3010

Swiss Cardiovascular Center Bern, Bern

8088

Kopfwehzentrum Hirslanden Zürich, Zurich

12683

Unfallkrankenhaus Berlin, Berlin

20246

Universitätsklinikum Hamburg, Hamburg

24149

Neurologisch-verhaltensmedizinische Schmerzklinik Kiel, Kiel

48129

Universitätsklinikum Münster, Münster

T2N 2T9

University of Calgary- Foothills Hospital, Calgary

Unknown

Alberta Health Services and the University of Alberta, Edmonton

V6Z 1Y6

University of British Columbia, Vancouver

K1H 1A2

University of Ottawa, Ottawa

M4S 1Y2

Davisville Medical Center, Toronto

H1T 1C8

Institut de Cardiologie de Montreal, Montreal

G1V 4G5

Centre Hospitalier Universitaire de Québec, Québec

06120

Martin-Luther-University Halle-Wittenberg, Halle

BN2 5BE

Royal Sussex County Hospital, Brighton

W2 1NY

St. Mary's Hospital Imperial College Healthcare NHS Trust, London

M23 9LT

South Manchester University Hospital, Manchester

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY